 Evogene Ltd. NASDAQ: EVGN TASE: EVGN.TA, a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries, by utilizing cutting edge computational biology technologies, announces today a letter to the shareholders from President and CEO, Ofer Haviv. 